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Aims: The goal of our study is to investigate the associations between 18 candidate genetic markers and
overweight/obesity.
Methods: A total of 72 eligible articles were retrieved from literature databases including PubMed, Embase,
SpingerLink, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wanfang. Meta-analyses of 18
genetic markers among 56,738 controls and 48,148 overweight/obese persons were done by Review Manager 5.0.
Results: Our results showed that SH2B1 rs7498665 polymorphism was significantly associated with the risk of
overweight/obesity (overall odds ratio (OR) = 1.21, 95% confidence interval (CI) = 1.09-1.34, P = 0.0004). Increased risk
of overweight/obesity was also observed in FAIM2 rs7138803 polymorphism (overall OR = 1.11, 95% CI = 1.01-1.22,
P = 0.04).
Conclusion: Our meta-analyses have shown the important role of 2 polymorphisms (SH2B1 rs7498665 and FAIM2
rs7138803) in the development of overweight/obesity. This study highlighted the importance of above two candi-
date genes (SH2B1 and FAIM2) in the risk of overweight/obesity.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2785487401176182.
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Overweight/obesity as a metabolic disorder is closely
associated with diabetes mellitus and cardiovascular dis-
ease, which are chronic diseases influencing the average
life expectancy [1,2]. In 2008, world health organization
(WHO) has reported that a large portion of adults
(>20 yr) were overweight (35%) and obese (12%) [3]. The
overweight/obesity will become an epidemic [4] and
cause a huge economic burden of society [4] in the near
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unless otherwise stated.The occurrence and the development of obesity are
influenced by both environmental and genetic factors
[5,6]. Environmental factors, such as poor nutritional
state and a lack of physical exercise, have an impact on
the development of overweight/obesity [7,8] through the
epigenetic modifications such as gene methylation [9].
Genetic polymorphisms can confer the susceptibility of
overweight/obesity and obesity-related morbidities [10].
Recent genome-wide association studies (GWAS) have
identified a handful of candidate genetic markers to the
risk of overweight/obesity [11].
In the present study, we performed a systematic search
for eligible studies in the meta-analyses. Our results
identified 18 polymorphisms among 16 genes that were
all the candidate genes of obesity. Among these genes,
GNB3 encodes β3-subunit protein which is involved in
the process of hypertension and obesity [12]. MTHFR
gene encodes methylenetetrahydrofolate reductase thatd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of 17 single nucleotide polymorphisms
Gene SNP Year Author Race Cases/
Controls (n)
Allele 1 Allele 2 Model
selected
H rogeneity P value Odds ratio
(95% confidence interval)(Case/Controls, n) (Case/Controls, n) (I2)%
GNB3 rs5443 1999 Siffert W Caucasian 92/207 108/392 76/122 Fixed 42 0.47 1.04 (0.93-1.16)
(C/T) 1999 Siffert W Asian Chinese 186/832 166/886 206/778
1999 Siffert W African 127/607 34/219 220/995
2000 Siffert W Caucasian 207/92 292/108 122/76
2001 Hinney A Caucasian 491/330 695/442 287/218
2001 Benjafield AV Caucasian 92/188 133/284 51/92
2001 Ohshiro Y Asian Japanese 208/150 215/148 201/152
2004 Suwazono Y Asian Japanese 505/2120 517/2177 493/2063
2008 Wang X Asian Chinese 129/270 442/285 376/255
2013 Hsiao TJ Asian Chinese 467/505 402/441 532/569
MTHFR rs1801133 2007 Terruzzi I Caucasian 84/52 90/61 78/43 Fixed 0 0.59 1.05 (0.87-1.27)
(C/T) 2010 Tavakkoly Bazzaz J Asian Iranian 74/207 109/306 39/108
2012 Yin RX Asian Chinese 751/978 1049/1383 453/573
CNR1 rs806381 2008 Benzinou M Caucasian 839/1726 1163/2362 515/1090 Fixed 0 0.5 1.04 (0.93-1.17)
(A/G) 2008 Jaeger JP Caucasian 430/317 613/464 247/170
2012 Zhuang M Asian Chinese 1662/1070 2345/1550 979/590
BDNF rs6265 2005 Friedel S Caucasian 183/283 342/448 81/118 Fixed 46 0.8 1.01 (0.92-1.11)
(G/A) 2009 Hotta K Asian Japanese 1127/1733 1367/2013 887/1453
2009 Marti A Caucasian 155/147 242/226 68/68
2011 Xi B Asian Chinese 1229/1619 1095/1554 1363/1684
2011 Rouskas K Caucasian 510/469 826/732 194/206
2012 Skledar M Caucasian 74/226 111/374 37/78
FAAH rs324420 2005 Sipe JC Caucasian 1094/1594 1777/984 411/204 Random 79 0.54 0.94 (0.76-1.16)
(C/A) 2005 Sipe JC African 507/107 687/161 327/53
2005 Sipe JC Asian 271/94 471/148 71/40
2007 Jensen DP Caucasian 4190/2507 6817/3991 1563/1023
2008 Durand E Caucasian 1517/1320 2473/2104 561/536
2008 Papazoglou D Caucasian 158/121 265/209 51/33
2008 Moneletone P Caucasian 378/110 614/194 142/26















Table 1 Characteristics of 17 single nucleotide polymorphisms (Continued)
ADRB1 rs1801253 2001 Rydén M Caucasian 141/157 206/214 76/100 Fixed 0 0.5 1.03 (0.94-1.14)
(C/G) 2004 Tafel J Caucasian 296/134 403/180 189/88
2007 Gjesing AP Caucasian 4575/3073 6781/4609 2369/1537
2008 Ohshiro Y Asian Japanese 180/132 284/215 76/49
SH2B1 rs7498665 2009 Hotta K Asian Japanese 1129/1735 1943/3003 315/467 Fixed 0 0.0004 1.21 (1.09-1.34)
(A/G) 2010 Shi J Asian Chinese 829/1859 1427/3317 231/401
2011 Beckers S Caucasian 1045/317 1223/401 867/223
2011 Rouskas K Caucasian 510/469 673/675 347/263
2012 Volckmar AL Caucasian 3139/424 3728/557 2550/311
PCSK1 rs6232 2009 Happé F Caucasian 3570/7933 6735/15028 405/838 Fixed 34 0.08 1.14 (0.97-1.12)






2013 Choquet H European American 263/547 485/1041 41/53
2013 Dušátková L Asian Czech 668/770 1255/1469 81/71
PCSK1 rs6235 2009 Happé F Caucasian 3559/7793 5164/11432 1954/4154 Fixed 0 0.26 1.04 (0.97-1.12)
(G/C) 2012 Villalobos-Comparán
M
South America Mexican 994/1336 1575/2156 413/516
2013 Choquet H European - American 263/547 368/793 158/301
2013 Choquet H African - American 453/251 740/432 166/70
2013 Dušátková L Asian Czech 670/772 996/1130 344/414
2014 Hsiao TJ Asian Chinese 290/175 406/229 174/121
NPY2R rs1047214 2006 Torekov SS Caucasian 939/4767 1026/5295 852/4239 Fixed 0 0.54 0.97 (0.88-1.07)
(T/C) 2007 Siddiq A Caucasian 953/1042 1048/1132 858/952
2007 Wang HJ Caucasian 184/183 189/169 179/197
2009 Zhang J Asian Chinese 705/1325 1171/2133 239/517
FAIM2 rs7138803 2009 Hotta K Asian Japanese 1125/1726 1408/2251 842/1201 Fixed 0 0.04 1.11 (1.01-1.22)
(G/A) 2011 Xi B Asian Chinese 1229/1619 1711/2332 747/906
2011 Rouskas K Caucasian 510/469 643/610 377/328
2013 Li C Asian Chinese 242/469 331/663 153/275
2013 Zhao XY Asian Chinese 371/393 534/565 208/221
SERPINE1 rs1799768 2001 Sartori MT Caucasian 93/79 95/84 91/74 Fixed 39 0.07 0.83 (0.67-1.02)
(4G/5G) 2002 Hoffstedt J Caucasian 317/188 305/141 329/235















Table 1 Characteristics of 17 single nucleotide polymorphisms (Continued)
2008 Solá E Caucasian 67/67 70/65 64/69
2008 Kinik ST Asian Turk 39/38 52/36 26/40
2011 Espino A South American Chilean 50/71 32/51 44/52
2012 Wingeyer SD South American
Argentine
110/111 92/109 128/113
PON1 rs854560 2011 Veiga L Caucasian 81/74 101/90 61/58 Fixed 31 0.4 0.87 (0.62-1.21)
(A/T) 2011 Martínez-Salazar MF South American
Mexican
63/64 114/101 12/27
2013 Rupérez AI Caucasian 177/81 210/219 137/143
PON1 rs662 2011 Veiga L Caucasian 81/74 68/44 94/104 Fixed 18 0.6 1.09 (0.79-1.51)
(G/A) 2011 Martínez-Salazar MF South American
Mexican
63/64 66/65 60/63
2013 Rupérez AI Caucasian 177/81 252/249 102/111
CETP TaqIB 2006 Huang ZY Asian Chinese 199/141 243/162 155/120 Fixed 0 0.23 0.91 (0.79-1.06)
(B1/B2) 2008 Srivastava N Asian Indian 159/278 153/263 165/293
2010 Ruan X Asian Chinese 934/924 1104/1028 764/820
2011 Huang Y Asian Chinese 206/132 250/155 162/109
UCP1 rs1800592 1998 Gagnon J Caucasian 674/311 1013/473 335/149 Random 60 0.23 1.19 (0.90-1.57)
(A/G) 2000 Proenza AM Asian Turk 136/94 189/131 83/57
2002 Kieć-Wilk B Caucasian 12/106 18/146 6/66
2002 Nieters A Caucasian 154/153 232/231 76/75
2003 Forga Ll Caucasian 159/154 258/244 60/64
2004 Ramis JM Caucasian 82/170 259/433 49/81
2008 Mottagui-Tabar S Caucasian 91/479 433/736 149/222
2009 Shen ZN Asian Chinese 127/257 129/240 125/274
ABCA1 rs2230806 2006 Porchay I Caucasian 2097/2947 2992/4238 1202/1656 Fixed 0 0.87 1.01 (0.90-1.13)
(G/A) 2007 Kitjaroentham A Asian Thai 112/117 143/143 81/91















Table 2 Characteristics of APOE ε2/ε3/ε4 polymorphism
Year Author Race Case/Controls (n) Genotypes (case/controls, n) Alleles (case/controls, n)
ε2/ε2 ε2/ε3 ε2/ε4 ε3/ε3 ε3/ε4 ε4/ε4 ε2 ε3 ε4
2003 Guerra A Caucasian 31/81 0/0 6/4 0/0 63/20 13/7 0/0 6/4 145/51 13/7
2008 Srivastava N Asian Indian 159/278 0/1 17/18 2/6 90/198 41/55 9/0 19/30 238/469 61/61
2010 Ergun MA Asian Chinese 38/42 0/2 2/0 12/4 8/9 16/26 0/1 14/8 34/44 28/32
2012 Zhang J Asian Chinese 282/172 1/3 46/16 7/2 186/123 40/27 2/1 55/24 458/289 51/31
2012 Zarkesh M Asian Iran 463/370 1/1 48/38 6/7 348/268 63/53 3/3 56/47 807/627 75/66
Module Case/Controls (n) Model selected Heterogeneity (I2)% P value OR (95% CI)
ε2/ε2/ε3/ε3 954/813 Fixed 0 0.12 0.35 (0.09-1.32)
ε2/ε3ε3/ε3 814/694 Fixed 48 0.07 1.33 (0.98-1.82)
ε2/ε4/ε3/ε3 695/618 Fixed 0 0.92 0.96 (0.45-2.05)
ε3/ε4/ε3/ε3 868/786 Fixed 28 0.7 1.05 (0.82-1.35)
ε4/ε4/ε3/ε3 695/618 Random 63 0.54 1.89 (0.25-14.46)
ε2/ε3 1832/1593 Fixed 23 0.26 1.16 (0.90-1.51)















Figure 1 Forest plots of the association studies between 17
SNPs and overweight/obesity.
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http://www.diagnosticpathology.org/content/9/1/56is shown to be associated with increased fasting homo-
cysteine [13]. MTHFR polymorphism is shown to be asso-
ciated with lipid metabolism in the elderly women [14].
CNR1 is shown to regulate the endocannabinoid system
that might stimulate the metabolism of lipogenesis
through central and peripheral mechanisms [15,16].
CNR1 is associated with low HDL dyslipidemia and a
common haplotype of CNR1 could be a protective fac-
tor of obesity-related dyslipidemia [17]. BDNF is shown
to play an important role in the development of several
neuronal systems [18]. As an effector on energy homeosta-
sis through MC4R signaling pathway, BDNF has an effect
on the glucose and lipid metabolism in obese diabetic ani-
mals [19,20]. FAAH gene encodes fatty acid amide hydro-
lase [21] and plays an important role in the development
of obesity [22]. ADRB1 is shown to mediate in lipolysis
and thus is important for obesity [23]. Rat study identifies
that ADRB1 mediates the sympathetic nervous system
(SNS) stimulation of thermogenesis in brown adipose
tissue [24]. SH2B1 is able to bind leptin to its receptor,
and thus increases the JAK2 activation which is involved
in the insulin and leptin signaling [25,26]. PCSK1 en-
codes prohormone convertase 1/3 that is a vital enzyme
in the regulation of a majority of neuroendocrine body
weight control [27]. A novel homozygous missense muta-
tion in PCSK1 leads to early-onset obesity [28]. NPY2R is
a presynaptic receptor [29] playing an inhibitory role in
the control of appetite regulation [30], and thus influences
the development of obesity [31]. FAIM2 (Fas apoptotic
inhibitory molecule 2) is an anti-apoptotic gene [32].
Mutations of FAIM2 which interferes with Fas-mediated
cell death confer risk for obesity [33]. SERPINE1 encodes
a member of serine proteinase inhibitor which influences
plasma PAI-1 activity with relation to obesity [34]. Serum
paraoxonase-1 (PON1) encoded by PON1 as an enzyme
associated with HDL-C could be a protector against oxi-
dative damage in obesity [35]. CETP protein product
transfers cholesterylesters from HDL to pro-atherogenic
apoB-lipoproteins and thus has an impact on the lipid
and HDL metabolism [36,37]. UCP1 encodes uncoup-
ling protein 1 that is mediated by long-chain fatty acids
(LCFAs) from brown adipose tissue [38]. UCP1 expres-
sion in adipose tissue has an impact on regulating the
thermogenesis and lipolysis [39,40]. Mitochondrial un-
coupling by UCP1 has demonstrated to be a target in
antiobesity therapies [41]. ABCA1 gene product medi-
ates the transport of cholesterol, phospholipids, and
other metabolites [42]. Exercise has an impact on ABCA1
expression along with increased HDL levels in obese boys
[43]. APOE plays a fundamental role with ligand-receptor
in uptaking lipoproteins, and thus participates in the lipid
metabolism [44]. In addition, APOE correlates with in-
flammation in adipose tissue in high-fat diet-induced
obesity [45].
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http://www.diagnosticpathology.org/content/9/1/56Meta-analysis is a systematic evaluation by combining
the results from collected studies [46,47]. The major ad-
vantages of meta-analysis are to improve the precision
and accuracy by pooling up the data from multiple
sources, and to analyze and quantify the inconsistency of
results and the publish bias [48]. In the present study,
we conducted comprehensive meta-analyses to identify
the contribution of 18 polymorphisms to overweight/
obesity.
Materials and methods
Literature search and data extraction
We performed the literature research using related
databases such as PubMed, Embase, SpingerLink, Web
of Science, Chinese National Knowledge Infrastructure
(CNKI), and Wanfang. The combination of keywords in
the literature search was obesity or overweight together
with polymorphism or mutation or variant or singleFigure 2 Forest plots of the association studies between APOE ε2/ε3/nucleotide polymorphism (SNP). The studies excluded
in the meta-analysis met the following criteria: (1) the
study had been included in the previous meta-analysis;
(2) the study was not involved with genetic testing; (3) the
study was not a case–control study. The criteria for over-
weight or obesity in adolescents and children were defined
by WHO [49,50]. Finally, we harvested 18 polymorphisms
of 16 genes in the current meta-analysis. These included
GNB3 rs5443, MTHFR rs1801133, CNR1 rs806381, BDNF
rs6265, FAAH rs324420, ADRB1 rs1801253, SH2B1
rs7498665, PCSK1 rs6232 and rs6235, NPY2R rs1047214,
FAIM2 rs7138803, SERPINE1rs1799768, PON1 rs854560
and rs662, CETP TaqIB, UCP1 rs1800592, ABCA1
rs2230806 and APOE ε2/ε3/ε4.
Statistical analysis
Meta-analysis was performed by using Statistical soft-
ware Review Manager 5.0 [51]. Forest plots included theε4 polymorphism and overweight/obesity.
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http://www.diagnosticpathology.org/content/9/1/56ORs with the corresponding 95% CIs, cochran’s Q and
the inconsistency index (I2). If there were no significant
heterogeneity (I2 < 50%, P > 0.05) of the studies in the
meta-analysis, we used a fixed-effect model for the ana-
lysis. Otherwise, a random-effect model was used for the
meta-analysis with large heterogeneity (I2 > 50%, P < 0.05).
The weight of each involved study was calculated what-
ever in fixed-effect or random-effect model in forest
plots by Review Manager 5.0. Two tailed P value < 0.05
was treated as significant. Power analyses were calcu-
lated by Power and Sample Size Calculation software
(v3.0.43) [52].Figure 3 Funnel plots of the studies of 17 SNPs involved in meta-anaResults
An initial search returned a total of 7,750 literatures
from databases including PubMed, Embase, SpingerLink,
Web of Science, Chinese National Knowledge Infrastruc-
ture (CNKI), and Wanfang. After a systematic filtration,
72 eligible articles, including 64 English, 6 Chinese, 1
German and 1 Spanish articles, were left for the meta-
analyses (Additional file 1: Table S1). The detailed informa-
tion for the retrieved studies was shown in Tables 1 and 2.
Heterogeneity is an important indicator to identify if
there is difference in the collected studies. According
to the extent of heterogeneity, we categorized thelysis.
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http://www.diagnosticpathology.org/content/9/1/56meta-analyses into three groups that have minimal (I2 = 0),
moderate (I2 < 50%), and significant heterogeneity (I2 ≥
50%), respectively. As shown in Figure 1, minimal hetero-
geneity (I2 = 0) was found for the meta-analyses of 10 poly-
morphisms that included MTHFR rs1801133, CNR1
rs806381, ADRB1 rs1801253, SH2B1 rs7498665, PCSK1
rs6235, NPY2R rs1047214, FAIM2 rs7138803, CETP TaqIB
and ABCA1 rs2230806. Moderate heterogeneity was
found for 5 polymorphisms, including BDNF rs6265 (I2 =
46%), PCSK1 rs6232 (I2 = 34%), GNB3 rs5443 (I2 = 42%),
PON1 rs854560 (I2 = 31%), PON1 rs662 (I2 = 18%), and
SERPINE1 rs1799768 (I2 = 39%). Significant heterogeneity
was found for UCP1 rs1800592 (I2 = 60%) and FAAH
rs324420 (I2 = 79%). Moreover, As shown in Figure 2,
various heterogeneities were shown in the meta-analyses
of APOE ε2/ε3/ε4 polymorphism under the seven gen-
etic models (ε2/ε3 versus ε3/ε3: I2 = 48%; ε2/ε4 versus
ε3/ε3: I2 = 0%; ε3/ε4 versus ε3/ε3: I2 = 28%; ε4/ε4 ver-
sus ε3/ε3: I2 = 63%; ε2/ε3 versus ε3/ε3: I2 = 0%; ε2 ver-
sus ε3: I2 = 23%; ε4 versus ε3: I2 = 65%). No obvious
publication bias was observed based on their funnel
plots (Figures 3 and 4).
Our results showed that SH2B1 rs7498665 was signifi-
cantly associated with the risk of overweight/obesity
among 6,142 cases and 4,345 controls from four studies
(overall OR = 1.21, 95% CI = 1.09-1.34, P = 0.0004, Figure 1).
Increased risk of overweight/obesity was also observed
in rs7138803 of FAIM2 among 3,477 cases and 4,676
controls from five studies (overall OR = 1.11, 95% CI =
1.01-1.22, P = 0.04, Figure 1). No evidence of association
was observed for the meta-analyses of the rest 16Figure 4 Funnel plots of the studies of APOE ε2/ε3/ε4 involved in mevariants (Figures 1 and 3). For the meta-analyses with
large heterogeneity, we further performed subgroup
meta-analyses by ethnicity. No significant association of
UCP1 rs1800592 with overweight/obesity was observed
in Caucasian (P = 0.13, I2 = 62%), and Asian (P = 0.59, I2 =
0%, Additional file 2: Figure S1). And the subgroup meta-
analysis of APOE ε2/ε3/ε4 polymorphism by excluding
the study of Srivastava et al. [53] didn’t produce any sig-
nificant association of APOE ε2/ε3/ε4 with overweight/
obesity (Additional file 3: Figure S2). There was no visual
publication bias in all the above meta-analyses (Additional
file 4: Figure S3).
Discussion
Current meta-analyses were performed among 48,148
cases and 56,738 controls from 72 studies, covering a
total of 6 populations, including Caucasian, Asian, Japanese-
American, European-American, African-American, South
American, and African. Among the tested 18 polymor-
phisms, there were two (SH2B1 rs7498665 and FAIM2
rs7138803) with significant association results (P < 0.05).
Power analysis also showed large power existed in our
meta-analyses of two significant polymorphisms including
SH2B1 rs7498665 (100%) and FAIM2 rs7138803 (100%).
SH2B1 encodes an adaptor protein associated with
leptin and insulin signaling in the lipid metabolism [54].
SH2B1 is an enhancer that may influence the phenotype
of obesity through JAK-STAT pathway [55], which is im-
portant in the development and function of adipocytes
[56]. SH2B1 acts as a mediator through PI3-kinase path-
way which is correlated with the biological actions ofta-analysis.
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http://www.diagnosticpathology.org/content/9/1/56leptin [26]. Many animal studies have shown that SH2B1
is involved in the development of obesity. SH2B1 through
its participation in the regulation of leptin sensitivity, en-
ergy metabolism and body weight [57]. SH2B1 has been
identified to be related to obesity through genome-wide
association studies (GWAS) [55]. Our meta-analysis of
SH2B1 rs7498665 was performed among 6,652 cases and
4,814 controls with four studies. Among the tested popu-
lations, no heterogeneity was observed (I2 = 0). Our results
confirmed the relationship between SH2B1 and the risk of
overweight/obesity (overall OR = 1.21, 95% CI = 1.09-1.34,
P = 0.0004, Figure 1).
FAIM2 is an anti-apoptotic gene that provides protection
from Fas-mediated cell death [32] that is associated with
extreme overweight by GWAS [58]. FAIM2 rs7138803
polymorphism is associated with increased risk of obes-
ity in Japanese [59]. But there is no relationship between
FAIM2 rs7138803 and obesity in Chinese [60]. Minor
allele frequency of rs7138803 in Chinese populations
ranges from 0.28 to 0.29, while FAIM2 rs7138803 is
monomorphic in Japanese and Caucasian populations.
Our meta-analysis among 3477 cases and 4676 controls
demonstrated that FAIM2 rs7138803 was associated
with the risk of overweight/obesity (overall OR = 1.11,
95% CI = 1.01-1.22, P = 0.04, Figure 1).
Although meta-analysis is an important method to
improve the precision and accuracy, to analyze and
quantify the published results [61-63], some disadvantages
exist in the meta-analysis. For the current meta-analyses,
several limitations need to be taken with cautions. Firstly,
obesity is always accompanied by other complications
such as coronary artery diseases and hypertension. These
confounding factors needed to be adjusted in the original
case–control studies. We were unable to obtain the related
information. Therefore we can’t exclude a chance of the
positive findings confounded by these obesity-related fac-
tors. Secondly, the significant result of FAIM2 rs7138803
needs to be validated in the future. However, after
Bonferroni’s correction by the number of testing, the
association of FAIM2 rs7138803 was unable to retain
significant. Thirdly, power analysis suggested moder-
ate power in the meta-analyses of MTHFR rs1801133
(power = 78.2%) and SERPINE1 rs1799768 (power = 69.4%)
The negative results of them might be caused by a lack of
power in our meta-analyses. Future studies with larger
samples may help clarify the contribution of these bio-
markers to the risk of overweight/obesity.
Our results identified significant associations between 2
polymorphisms (SH2B1 rs7498665 and FAIM2 rs7138803)
and overweight/obesity. Moreover, overweight/obesity is a
complicated disease influenced by both genetic and envir-
onmental factors. The potential mechanism of interaction
between gene and environment could be taken into con-
sideration in the future study. Well-designed studies withlarge samples could help elucidate the contribution of
above polymorphisms to overweight/obesity.
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